182 related articles for article (PubMed ID: 16682761)
1. Ultrasound diagnostic schema for the determination of increased risk for chromosomal fetal aneuploidies in the first half of pregnancy.
Sieroszewski P; Perenc M; Baś-Budecka E; Suzin J
J Appl Genet; 2006; 47(2):177-85. PubMed ID: 16682761
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic methods for fetal malformations in the first half of pregnancy].
Sieroszewski P; Suzin J; Baś-Budecka E
Ginekol Pol; 2003 Oct; 74(10):1276-83. PubMed ID: 14669430
[TBL] [Abstract][Full Text] [Related]
3. First-trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free β-hCG and PAPP-A: a 5-year prospective study.
Ghaffari SR; Tahmasebpour AR; Jamal A; Hantoushzadeh S; Eslamian L; Marsoosi V; Fattahi F; Rajaei M; Niroomanesh S; Borna S; Beigi A; Khazardoost S; Saleh-Gargari S; Rahimi-Sharbaf F; Farrokhi B; Bayani N; Tehrani SE; Shahsavan K; Farzan S; Moossavi S; Ramezanzadeh F; Dastan J; Rafati M
Ultrasound Obstet Gynecol; 2012 May; 39(5):528-34. PubMed ID: 21793085
[TBL] [Abstract][Full Text] [Related]
4. [Prospective cohort study of fetal nuchal translucency in first-trimester and pregnancy outcome].
Tang HR; Zhang Y; Ru T; Li J; Yang L; Xu Y; Duan HL; Wang Y; Wang Y; Hu YL; Zhang Y; Zheng MM
Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):94-99. PubMed ID: 32146737
[No Abstract] [Full Text] [Related]
5. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
6. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
Chen X; Chang Y; Cui HY; Ren CC; Yu BY
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
[TBL] [Abstract][Full Text] [Related]
7. Interest of foetal nasal bone measurement at first trimester trisomy 21 screening.
Weingertner AS; Kohler M; Firtion C; Vayssière C; Favre R
Fetal Diagn Ther; 2006; 21(5):433-8. PubMed ID: 16912493
[TBL] [Abstract][Full Text] [Related]
8. Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies.
Zoppi MA; Ibba RM; Axiana C; Floris M; Manca F; Monni G
Prenat Diagn; 2003 Jun; 23(6):496-500. PubMed ID: 12813765
[TBL] [Abstract][Full Text] [Related]
9. [Nasal bone (NB) length measurement in the first trimester of pregnancy in Polish population and its validity as fetal aneuploidy indicator].
Sieroszewski P; Baś-Budecka E; Perenc M
Ginekol Pol; 2007 Aug; 78(8):616-20. PubMed ID: 18050610
[TBL] [Abstract][Full Text] [Related]
10. First-trimester assessment of nasal bone using retronasal triangle view: a prospective study.
Adiego B; Martinez-Ten P; Illescas T; Bermejo C; Sepulveda W
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):272-6. PubMed ID: 23733531
[TBL] [Abstract][Full Text] [Related]
11. Nasal bone in screening for T21 at 11-13 + 6 weeks of gestation - a multicenter study.
Węgrzyn P; Czuba B; Serafin D; Cnota W; Dubiel M; Mączka M; Zarotyński D; Ruci A; Wielgoś M; Sodowski K; Borowski D
Ginekol Pol; 2016; 87(11):751-754. PubMed ID: 27958633
[TBL] [Abstract][Full Text] [Related]
12. Additional performance of nasal bone in first trimester screening.
Kozlowski P; Knippel AJ; Froehlich S; Stressig R
Ultraschall Med; 2006 Aug; 27(4):336-9. PubMed ID: 16596511
[TBL] [Abstract][Full Text] [Related]
13. [The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects].
Baś-Budecka E; Perenc M; Sieroszewski P
Ginekol Pol; 2010 Apr; 81(4):272-6. PubMed ID: 20476599
[TBL] [Abstract][Full Text] [Related]
14. The Value of Detailed First-Trimester Ultrasound Anomaly Scan for the Detection of Chromosomal Abnormalities.
Tekesin I
Ultraschall Med; 2019 Dec; 40(6):743-748. PubMed ID: 30241105
[TBL] [Abstract][Full Text] [Related]
15. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO
Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869
[TBL] [Abstract][Full Text] [Related]
16. Nasal bone in screening for Trisomy 18 and 13 at 11-13 + 6 weeks of gestation - own experiences.
Czuba B; Maczka M; Cnota W; Wloch A; Jagielska A; Niesluchowska-Hoxha A; Borowski D
Ginekol Pol; 2020; 91(5):256-261. PubMed ID: 32495931
[TBL] [Abstract][Full Text] [Related]
17. Nuchal translucency and nasal bone in first-trimester ultrasound screening for aneuploidy in multiple pregnancies.
Sepulveda W; Wong AE; Casasbuenas A
Ultrasound Obstet Gynecol; 2009 Feb; 33(2):152-6. PubMed ID: 18985621
[TBL] [Abstract][Full Text] [Related]
18. Absent nasal bone at 11-14 weeks of gestation and chromosomal defects.
Cicero S; Longo D; Rembouskos G; Sacchini C; Nicolaides KH
Ultrasound Obstet Gynecol; 2003 Jul; 22(1):31-5. PubMed ID: 12858299
[TBL] [Abstract][Full Text] [Related]
19. Second-trimester soft markers: relation to first-trimester nuchal translucency in unaffected pregnancies.
Miguelez J; De Lourdes Brizot M; Liao AW; De Carvalho MH; Zugaib M
Ultrasound Obstet Gynecol; 2012 Mar; 39(3):274-8. PubMed ID: 21484908
[TBL] [Abstract][Full Text] [Related]
20. Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.
Monni G; Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C
Croat Med J; 2005 Oct; 46(5):786-91. PubMed ID: 16158472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
